Neuropharmacology & Neurotherapeutics
Clopidogrel was developed as a safer and more effective alternative to aspirin for the prevention and treatment of cerebral and cardiovascular ischemic events. Clopidogrel is indicated for the reduction of thrombosis in recent myocardial infarction, recent stroke, or established peripheral arterial disease. Clopidogrel is contraindicated in patients with active pathologic bleed.
Jul. 17, 2021